ArticleJournal of the ASEAN Federation of Endocrine Societies2025

Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease: A Real-World Study at a Diabetes Center in Bangkok.

Peachaphol Chongvoranond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.